Abstract: [Problem] To provide a novel therapeutic agent for nocturnal pollakiuria. [Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.

Abstract: [Problem] To provide a novel therapeutic agent for nocturnal pollakiuria. [Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.

Abstract: [Problem] To provide a novel therapeutic agent for nocturnal pollakiuria. [Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.

Abstract: A drug for treatment of patients having tinnitus associated with sudden hearing loss, comprising neramexane or a pharmaceutically acceptable salt thereof, wherein the morbidity period of the patient having tinnitus associated with sudden hearing loss is 48 months or longer.

Abstract: A drug for treatment of patients having tinnitus associated with age-related hearing loss, comprising neramexane or a pharmaceutically acceptable salt thereof.

Abstract: An elongated sheet for a medicine packaging bag is provided. The sheet can be folded centrally in a width direction and a medicine introduced between its two-folded halves. The sheet can be thermal-bonded along an entire width ahead of and behind the medicine and along an entire length of open edge portions of the two-folded halves, thus forming the medicine packaging bag. A number of fine tearing cuts can be formed in a portion beginning at a distance (t) from an end edge of the open edge portions in a longitudinal direction of the sheet. A tearing cut-less portion can be formed between the cut portion and the end edge of the open edge portions. The tearing cut-less portion inhibits tears caused by tension through the cut when the sheet is drawn out. The bag can be easily torn by hand due to the cut portion.

Abstract: One of a function as a direction key and a function as a confirmation key is executed by a user pressing a display with a finger. When a pressing force detector detects perpendicular movement of the display to a side of an upper surface of the information processing terminal body and a sensor detects sliding of the display in any direction of a side wall surface of the information processing terminal body, the function as the direction key is executed when the moving distance detected by the sensor exceeds a predetermined movement threshold, and the function as the confirmation key is executed when the moving distance is within the movement threshold. Accordingly, it is possible to allow the user to operate the display more intuitively and easily, and to prevent malfunction without disturbing compactness and the like while securing a maximum screen area.

Abstract: There is provided an elongated sheet (10) for a medicine packaging bag, which prevents tear of cuts (b, 16) caused by a tension during travel of the sheet, etc. and which allows a medicine packaging bag (A) to easily tear and thus open. The sheet (10) is folded centrally in a width direction and a medicine (a) is introduced between its two-folded halves (11, 11). The sheet (10) is thermal-bonded (12, 13) along an entire width ahead of and behind the medicine (a) and along an entire length of open edge portions of the two-folded halves (11, 11), thus forming the medicine packaging bag. A thermal-bonded portion (13) in the open edge portions is formed inwardly. A large number of fine tearing cuts (16) (4 mm width) are formed inwardly from an end edge (17) of the open edge portions by 1 mm between the thermal-bonded portion (13) and the open edge portions along an entire length in a longitudinal direction of the sheet (10).